Top Story

Triglycerides examined as potential CV therapy target

October 31, 2014

BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, highlights a symposium at the Cardiometabolic Health Congress that examined triglycerides as a target of CV therapy.

The session included discussion of analyses of patients with high triglyceride levels and low HDL cholesterol who exhibited benefits from therapies intended to lower triglycerides, such as niacin or omega-3 fatty acids. Davidson acknowledged that the National Lipid Association and the International Atherosclerosis Society both endorse non-HDL cholesterol targets for high-risk patients, and suggested that such targets should be considered for patients with elevated triglycerides.

In the Journals

PFO closure may be cost-effective in long term

October 31, 2014
Percutaneous patent foramen ovale closure was more cost effective than medical therapy during the long term in a recent study published in the American Journal of
Meeting News Coverage

Newly donated blood reduced complications after cardiac surgery

October 31, 2014
Patients undergoing cardiac surgery experienced a lower rate of complications when receiving blood donated within 14 days, according to data presented at the Canadian…
figure Meeting News Coverage

Genetic predisposition to elevated LDL tied to aortic valve calcium, aortic stenosis

October 31, 2014
New research provides evidence of a causal association between LDL and aortic valve disease. Researchers found that genetic predisposition to elevated LDL was associated…
More News Headlines »
CME
figure

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »
Meeting News Coverage Video
figure

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at…
More »
CME
figure

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »